Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 510 (7503), 68-75

Sphingolipid Lysosomal Storage Disorders

Affiliations
Review

Sphingolipid Lysosomal Storage Disorders

Frances M Platt. Nature.

Abstract

Lysosomal storage diseases are inborn errors of metabolism, the hallmark of which is the accumulation, or storage, of macromolecules in the late endocytic system. They are monogenic disorders that occur at a collective frequency of 1 in 5,000 live births and are caused by inherited defects in genes that mainly encode lysosomal proteins, most commonly lysosomal enzymes. A subgroup of these diseases involves the lysosomal storage of glycosphingolipids. Through our understanding of the genetics, biochemistry and, more recently, cellular aspects of sphingolipid storage disorders, we have gained insights into fundamental aspects of cell biology that would otherwise have remained opaque. In addition, study of these disorders has led to significant progress in the development of therapies, several of which are now in routine clinical use. Emerging mechanistic links with more common diseases suggest we need to rethink our current concept of disease boundaries.

Similar articles

See all similar articles

Cited by 74 articles

See all "Cited by" articles

References

    1. Mol Genet Metab. 2003 Jun;79(2):104-9 - PubMed
    1. Baillieres Clin Haematol. 1997 Dec;10(4):657-89 - PubMed
    1. PLoS One. 2009 Sep 11;4(9):e6951 - PubMed
    1. Ann Neurol. 2004 Nov;56(5):642-9 - PubMed
    1. QJM. 1996 Sep;89(9):691-4 - PubMed

MeSH terms

LinkOut - more resources

Feedback